Does Ibuprofen Worsen COVID-19?

Nicholas Moore (), Bruce Carleton, Patrick Blin, Pauline Bosco-Levy and Cecile Droz
Additional contact information
Nicholas Moore: Universityd of Bordeaux
Bruce Carleton: University of British Columbia
Patrick Blin: Universityd of Bordeaux
Pauline Bosco-Levy: Universityd of Bordeaux
Cecile Droz: Universityd of Bordeaux

Drug Safety, 2020, vol. 43, issue 7, No 1, 614 pages

Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-020-00953-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:43:y:2020:i:7:d:10.1007_s40264-020-00953-0

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-020-00953-0

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().